Armstrong Advisory Group’s iShares Biotechnology ETF IBB Stock Holding History

Armstrong Advisory Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.6K	Hold	187	–	–	﹤0.01%	493
2026 Q1	$31.6K	Hold	187	–	–	﹤0.01%	484
2025 Q4	$31.6K	Hold	187	–	–	﹤0.01%	479
2025 Q3	$27K	Hold	187	–	–	﹤0.01%	506
2025 Q2	$23.7K	Hold	187	–	–	﹤0.01%	511
2025 Q1	$24.7K	Hold	187	–	–	﹤0.01%	477
2024 Q4	$24.7K	Hold	187	–	–	﹤0.01%	477
2024 Q3	$27.2K	Hold	187	–	–	﹤0.01%	456
2024 Q2	$25.7K	Hold	187	–	–	﹤0.01%	453
2024 Q1	$25.4K	Hold	187	–	–	﹤0.01%	440
2023 Q4	$25.4K	Hold	187	–	–	﹤0.01%	440
2023 Q3	$22.9K	Sell	187 -14	-7%	-$1.78K	﹤0.01%	460
2023 Q2	$25.5K	Hold	201	–	–	﹤0.01%	446
2023 Q1	$26K	Hold	201	–	–	﹤0.01%	431
2022 Q4	$26.4K	Buy	+201	New	+$26K	﹤0.01%	432

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Armstrong Advisory Group's IBB Position: Q2 2026 in Review

Armstrong Advisory Group held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 187 shares worth $35.6K. The position accounts for ﹤0.01% of the portfolio, ranked #493.

Armstrong Advisory Group first reported a position in IBB in Q4 2022 and has held it in 15 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Armstrong Advisory Group held 187 shares of iShares Biotechnology ETF worth $35.6K as of Q2 2026.
Armstrong Advisory Group left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #493 holding.
Armstrong Advisory Group first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 15 quarters since.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.